Brief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals
Aug 27 (Reuters) - Tanvex Biopharma 6541.TW :
* ANNOUNCES MERGER PLAN WITH UNIT OF BORA PHARMACEUTICALS
6472.TW
* TANVEX THE PLANNED MERGER WOULD BE ACHIEVED VIA 1:1 STOCK
SWAP
* TANVEX SAYS THE PLANNED MERGER IS SUBJECT TO REGULATORY
APPROVAL
Source text for Eikon: ID:nMOP1YGG8D
Further company coverage: 6541.TW
(Reporting by Faith Hung)
((faith.hung@thomsonreuters.com;))
Recent news on BORA PHARMACEUTICALS
See all newsAI shortens drug discovery to around 1 year in China, Insilico CEO says
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine
Brief: Bora Pharmaceuticals & GSK Sign $250M Five Year Global Manufacturing Contract
Brief: Bora Pharmaceuticals Says Jan-Sept Net Profit T$2.65 Bln